0
Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South. (academic.oup.com)
Authors:
Colasanti JA
… Collins LF
Journal:
Clinical Infectious Diseases
Published:
2026-04-30
DOI:
https://doi.org/10.1093/cid/ciaf425
Comments
Login to comment.
No comments yet. Be the first!